Shifting Strategy, Roche Partners With Kite, J&J To Expand Cancer Drug’s Potential
Bloomberg News (3/23, Koch) reports that Roche
“is opening the door to more external partnerships as its latest and most
promising tumor-fighting treatment heads for approval this year.” In the past
week, Roche has partnered with Kite Pharma Inc. and Johnson & Johnson “to
explore combinations using its experimental drug atezolizumab.” The
“partnerships with Kite and J&J mark a small shift in Roche’s strategy,
which has emphasized using its own, large pool of potential compounds and
medicines to find new cancer-drug combinations.”
This is great news for cancer treatment progress. Try IMI's Chemo-Vent™ needles when reconstituting and withdrawing cytotoxic anti-neoplastic agents. We take pride in helping to supply the tools needed to save lives.
No comments:
Post a Comment